Rogaratinib, palbociclib and fulvestrant in advanced hormone receptor-positive (HR+), FGFR1/2-positive breast cancer: Phase I trial plus an expansion cohort

Pernas, S; Hernando, C; Bermejo, B; Martinez-Janez, N; Saenz, JAG; Morales, S; Manso, L; Silva, J; Guerra, JA; Malon, D; Mouron, S; Caleiras, E; Quintela-Fandino, M

CANCER RESEARCH, 2022; 82 (4):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索